Llwytho...
The Future of “Omics” in Hypertension
Despite decades of research and clinical practice, the pathogenesis of hypertension remains incompletely understood, and blood pressure is often suboptimally controlled. “Omics” technologies allow the description of a large number of molecular features and have the potential to identify new factors...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Can J Cardiol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Pulsus Group
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5417769/ https://ncbi.nlm.nih.gov/pubmed/28161100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cjca.2016.11.023 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|